A novel technology-driven enzyme replacement therapy for Pompe disease.
- DOI
- 10.1016/j.omta.2026.201867
- Published
- 2026 Dec 10
- Container
- Molecular therapy. Advances
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.omta.2026.201867,
title = {A novel technology-driven enzyme replacement therapy for Pompe disease.},
author = {Meena NK and Gray K and Roberts J and DiGruccio M and Weaver V and Liu L and Do H and Gotschall RR and Raben N},
year = {2026},
journal = {Molecular therapy. Advances},
doi = {10.1016/j.omta.2026.201867},
url = {https://doi.org/10.1016/j.omta.2026.201867}
}RIS
TY - JOUR TI - A novel technology-driven enzyme replacement therapy for Pompe disease. AU - Meena NK AU - Gray K AU - Roberts J AU - DiGruccio M AU - Weaver V AU - Liu L AU - Do H AU - Gotschall RR AU - Raben N PY - 2026 JO - Molecular therapy. Advances DO - 10.1016/j.omta.2026.201867 UR - https://doi.org/10.1016/j.omta.2026.201867 ER -
APA
NK, M., K, G., J, R., M, D., V, W., L, L., H, D., RR, G., & N, R. (2026). A novel technology-driven enzyme replacement therapy for Pompe disease.. Molecular therapy. Advances. https://doi.org/10.1016/j.omta.2026.201867
Source records
- pubmed · retrieved 2026-11-10T09:58:54.681Z